1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Pro Medicus Limited

Pro Medicus Limited

PMCUF
Pro Medicus LimitedUS flagOther OTC
145.00
USD
+10.20
- -
15.15BMarket Cap
Pro Medicus Limited
PMCUF
(Other OTC)

Recent

price

145.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.19
0.14
0.11
0.11
0.14
0.17
0.27
0.31
0.35
0.48
0.55
0.65
0.9
1.2
1.55
2.04
Revenue per Share
0.04
0.01
0.02
0.05
0.02
0.03
0.06
0.09
0.12
0.18
0.22
0.3
0.43
0.58
0.79
1.1
Basic EPS, GAAP
0.07
0.06
0.06
0.04
0.04
0.04
0.11
0.14
-0.06
-0.07
-0.08
-0.07
-0.09
-0.06
-0.06
-0.07
Free Cash Flow per Basic Share
0.02
0.02
- -
0.02
0.02
0.02
0.02
0.03
0.05
0.1
0.11
0.13
0.18
0.25
0.35
0.47
Dividend per Share
0.18
0.16
0.17
0.21
0.2
0.21
0.26
0.32
0.39
0.38
0.5
0.66
0.91
1.24
1.89
2.62
Book Value per Share
0.14
0.14
0.15
0.21
0.21
0.22
0.27
0.19
0.28
0.3
0.4
0.59
0.76
1.12
1.61
2.26
Tangible Book Value per Share
100
100
100
100
100
100
101
102
103
104
104
104
104
104
104
104
Basic Weighted Avg Shares
19
14
11
11
14
17
28
32
36
50
57
68
93
125
161
213
Sales/Revenue/Turnover
26.22
9.28
0.68
-10.83
16.48
19.17
34.58
44.77
46.8
50.8
52.88
62.41
66.73
67.12
69.49
74.03
Operating Margin (%)
3
3
3
3
3
3
4
4
5
6
8
7
7
8
9
7
Depreciation Expense
4
1
2
5
2
3
6
9
13
19
23
31
44
61
83
115
Net Income, GAAP
31.25
28.14
25.81
- -
38.46
37.07
32.95
30.5
26.64
26.79
23.13
28.04
29.55
29.58
28.93
29.45
Effective Tax Rate (%)
20.42
3.6
15.92
46
10.59
18.42
23.16
29.54
35.48
38.19
40.64
45.48
47.58
48.6
51.29
54.12
Profit Margin (%)
7
3
6
14
13
13
17
23
28
47
63
70
93
133
173
237
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
1
2
2
LT Debt
17
15
16
21
21
22
27
35
46
49
60
82
102
139
188
257
Total Equity
20.58
5.63
0.35
- -
5.83
8.99
24.26
29.4
29.66
38.58
41.03
41.04
44.74
45.82
46.98
48.82
Return on Invested Capital (%)
22.7
2.95
10.62
- -
7.4
15.51
26.8
31.49
34.58
47.76
49.48
49.22
52.81
53.26
50.18
48.46
Return on Capital (%)
22.7
2.95
10.62
26.9
7.4
15.51
26.8
31.49
34.58
47.76
50.71
51.22
54.39
54.24
50.78
48.9
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.2%
33.76%
36.88%
Free Cash Flow
9.05%
0.1%
10.22%
Net Income, GAAP
44.17%
37.98%
39.16%
Sales/Revenue/Turnover
29.08%
30.4%
31.89%
Total Cash Common Dividend
39.34%
35.22%
34.36%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
125
2024
- -
- -
- -
- -
161
2025
- -
- -
- -
- -
213

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.58
2024
- -
- -
- -
- -
0.79
2025
- -
- -
- -
- -
1.1

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.25
2024
- -
- -
- -
- -
0.35
2025
- -
- -
- -
- -
0.47
Similar Companies
Pharmagest Interactive S.A. (PHA.PA)
Pear Therapeutics, Inc. (PEAR)
Minerva Surgical, Inc. (UTRS)
CareCloud, Inc. (MTBCO)
CareCloud, Inc. (CCLDO)
Volpara Health Technologies Limited (VPAHF)
Business
Pro Medicus Limited is an Australia-based healthcare informatics company specializing in the development and supply of proprietary medical imaging software and integrated IT solutions for hospitals, imaging centers, and healthcare groups globally. Its core products include advanced visualization software, enterprise imaging solutions, radiology workflow management systems, and cloud-based imaging services that enable seamless streaming and remote diagnostic capabilities. The company operates through its flagship Visage brand, which encompasses high-performance image viewer, workflow, and archive platforms, as well as expanding offerings into digital pathology, cardiology, and ophthalmology to address broader medical imaging needs across multiple specialties. Founded in 1983 and headquartered in Melbourne, Australia, Pro Medicus serves a diverse client base including major healthcare providers and academic institutions primarily in North America, Europe, and Australia. In recent developments, Pro Medicus has accelerated growth through significant long-term contracts, including a record A$330 million 10-year cloud-based enterprise imaging agreement with Trinity Health, covering 93 hospitals across 26 U.S. states, and multiple multimillion-dollar renewals and upgrades with prominent healthcare systems such as NYU Langone Health and University of Florida. The company has also launched new enterprise imaging products targeting additional medical specialties such as cardiology and ophthalmology and is advancing artificial intelligence capabilities within its software portfolio. Pro Medicus made a strategic A$10 million investment in 4DMedical to support respiratory imaging technology and expand its innovation pipeline. Furthermore, it announced a forthcoming product launch in digital pathology in late 2025 and continues to pursue strategic M&A opportunities to enhance its product suite and market position. This expansion aligns with its growth focus on cloud-based digital health data services and increasing geographical presence, particularly in the North American market. Pro Medicus operates with approximately 69 employees and maintains a significant footprint in healthcare informatics, underpinning clinical decision-making through innovative imaging software solutions that promote efficient workflow, improved diagnostic accuracy, and enhanced patient outcomes worldwide. The company remains committed to developing integrated healthcare IT solutions that respond to the evolving demands of medical imaging and digital health ecosystems.

Company News

APIChatGPT

  • seekingalpha.com

    Pro Medicus Limited (PMDIY) Q2 2026 Earnings Call Transcript

  • defenseworld.net

    Pro Medicus (OTCMKTS:PMCUF) Shares Down 4% – Time to Sell?

  • seekingalpha.com

    Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q2 2025 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript